{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:36:32Z","timestamp":1781195792790,"version":"3.54.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Hypertension, endothelial dysfunction, and inflammation are associated with increased cardiovascular mortality in end-stage kidney disease. We evaluated the effects of ACE (angiotensin-converting enzyme) inhibition on biomarkers of endothelial dysfunction and inflammation in hypertensive children with end-stage kidney disease on maintenance hemodialysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In a randomized, double-blind, placebo-controlled trial, 135 (72 males\/63 females) children and adolescents (age 7\u201315 years) were randomly assigned to treatment with either 2.5 mg once daily ramipril (n=68) or placebo (n=67) for 16 weeks. Primary outcome were the serum concentrations of asymmetrical dimethylarginine, a marker of endothelial dysfunction and hs-CRP (high-sensitivity C-reactive protein), a marker of inflammation. Changes in IL-6 (interleukin-6), TNF-\u03b1 (tumor necrosis factor-alpha), systolic (S), and diastolic (D) blood pressure were secondary outcomes. Change in potassium levels and incidence of hyperkalemia were among the safety parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n              Ramipril, but not placebo, significantly reduced serum levels of asymmetrical dimethylarginine (\u221279.6%;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001), hs-CRP (\u221246.5%;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001), IL-6 (\u221227.1%;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001), and TNF-\u03b1 (\u221251.7%;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Systolic blood pressure and diastolic blood pressure were significantly lowered in both groups with a greater reduction in children receiving ramipril (median between-group differences \u221212.0 [95% CI \u221218.0 to \u22129.5] and \u22129.0 [95% CI \u221212.0 to \u22124.5];\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001, respectively). Changes in asymmetrical dimethylarginine, hs-CRP, IL-6, or TNF-\u03b1 in the ramipril group did not significantly correlate with blood pressure reductions. No severe cases of hyperkalemia or other serious treatment-associated adverse events were observed.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Ramipril improves biomarkers of endothelial dysfunction and inflammation in hypertensive children on maintenance hemodialysis in addition to its efficacious and safe potential to lower blood pressure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              ; Unique identifier: NCT04582097.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/hypertensionaha.122.19312","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T18:00:35Z","timestamp":1657735235000},"page":"1856-1865","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Ramipril on Biomarkers of Endothelial Dysfunction and Inflammation in Hypertensive Children on Maintenance Hemodialysis: the SEARCH Randomized Placebo-Controlled Trial"],"prefix":"10.1161","volume":"79","clinical-trial-number":[{"clinical-trial-number":"nct04582097","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-4971","authenticated-orcid":true,"given":"Areej Mohamed","family":"Ateya","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt (A.M.A., S.M.S., R.E.B., N.A.S.)."},{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany (A.M.A., R.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"El Hakim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt (I.E.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mahmoud","family":"Shahin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt (A.M.A., S.M.S., R.E.B., N.A.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"El Borolossy","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt (A.M.A., S.M.S., R.E.B., N.A.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-211X","authenticated-orcid":true,"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany (A.M.A., R.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2611-4853","authenticated-orcid":true,"given":"Nagwa Ali","family":"Sabri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt (A.M.A., S.M.S., R.E.B., N.A.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3681-9"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031643"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312705"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.081"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318063"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027213"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(01)07217-8"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082359"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015050562"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000052939.59093.45"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000618"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171773"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(01)00727-4"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2020.09.016"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000107410"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0162-x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00802.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902066"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018010036"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.12.015"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001039"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/65823"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000163132.84890.c4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1751-5"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.31"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x05vm605oa"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq159"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy175"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080926"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10441015"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-1-200401060-00006"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753944708091777"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.12.044"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.10.026"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011030287"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000339023"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011717"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(09)70508-2"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.232"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01440209"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.11.017"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04304-9"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.01.008"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07821109"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000072705"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.122.19312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:35:36Z","timestamp":1715596536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.122.19312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.122.19312"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.122.19312","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"2022-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}